Graham Pawelec, MA, PhD,
Professor of Experimental Immunology
University of Tuebingen Center for Medical, Germany
Cancer Solutions Program Consultant, Health Sciences North Research Institute, Sudbury, ON, Canada
Visiting Professor of Cancer Immunology, John van Geest Cancer Research Center, Nottingham Trent University, Nottingham UK
We are currently living through a revolution in cancer treatment. Despite decades of scepticism, at long last, cancer immunotherapy is delivering on its promise. There remain vast challenges, both scientific, medical, regulatory and commercial, to the fully successful application of these therapies to all patients in need. These crucial issues will be critically considered in this special session on "Immunotherapy of Cancer: triumphs and challenges". I welcome all interested parties to actively participate in this discussion taking place on the occasion of the 3rd Cancer Research and Targeted Therapy conference (CRT-2018), August 6-8, 2018 at the Renaissance London Heathrow Hotel, London, UK.